SpinalCyte’s CybroCell Dermal Fibroblasts signals positive Phase 1/2 Clinical Trial Results Read more
MOLOGEN forays into global co-development agreement with ONCOLOGIE for lead compound lefitolimod Read more
Merck overturns APECS Study assessing Verubecestat (MK-8931) for Prodromal Alzheimer’s Disease Read more
Sanofi announces new safety data for investigational avalglucosidase alfa in patients with Pompe disease Read more
Bavarian Nordic announces positive results of Pivotal Phase 3 Study of IMVAMUNE smallpox vaccine Read more